KLF10 and neoplasm: SID peptide inhibits the combination of TIEG1 and PAH2, which is to inhibit the TGFβ/SMAD signal transduction pathway involved in TIEG1, so that the expression of Smad2 is down-regulated, and the EMT of tumor is inhibited to a certain extent (72).